Abstract
The prevalence of autoimmune diabetes was assessed in 113 indigenous and 1555 non-indigenous participants in the Fremantle Diabetes Study Phase II. Both type 1 diabetes (3.5% vs. 8.2%) and latent autoimmune diabetes of adults diagnosed based on glutamic acid decarboxylase antibody (GADA) positivity (1.0% vs. 5.7%) were lower in Aboriginal participants (P = 0.101 and 0.039 respectively). Six Aboriginals with GADA-negative type 2 diabetes were positive for tyrosine phosphatase-related islet antigen 2 antibodies but did not exhibit relative insulin deficiency.
| Original language | English |
|---|---|
| Pages (from-to) | 659-663 |
| Number of pages | 5 |
| Journal | Internal Medicine Journal |
| Volume | 55 |
| Issue number | 4 |
| Early online date | 18 Mar 2025 |
| DOIs | |
| Publication status | Published - Apr 2025 |
Funding
| Funders | Funder number |
|---|---|
| NHMRC National Health and Medical Research Council | 1154192 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Prevalence of autoimmune diabetes among Aboriginal Australians: the Fremantle Diabetes Study Phase II'. Together they form a unique fingerprint.Projects
- 1 Finished
-
MRFF - Community-based studies of diabetes and infectious diseases
Davis, T. (Investigator 01)
NHMRC National Health and Medical Research Council
1/01/19 → 31/12/23
Project: Research
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver